A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes

While there are limitations to the interpretation of results from a study using RWD, it is reassuring that there was no increase in pulmonary toxicity attributable to inhaled TI for treatment of diabetes with respect to lung cancer, COPD, emphysema, and chronic bronchitis.

Authors

IRL HIRSCH
Todd Burstain
A. G. Lynn

Institutions

University of Washington (US)
Jaeb Center for Health Research (US)
University of Washington Applied Physics Laboratory (US)

Publication Details

Journal: Diabetes Technology & Therapeutics
Published: 2026-01-21
DOI: https://doi.org/10.1177/15209156251412816
Primary Topic: Inhalation and Respiratory Drug Delivery
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes

IRL HIRSCH, Todd Burstain, A. G. Lynn

Jan 21, 2026

Diabetes Technology & Therapeutics

Inhalation and Respiratory Drug Delivery

article

A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes

IRL HIRSCH, Todd Burstain, A. G. Lynn

January 21, 2026article en

Abstract

Diabetes Technology & Therapeutics

University of Washington (US), Jaeb Center for Health Research (US), University of Washington Applied Physics Laboratory (US)

Good health and well-being

Openalex Percentile: Top 82%

Inhalation and Respiratory Drug Delivery

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.